Teva Pharmaceutical Industries Limited (TEVA): David Einhorn Trims Holding

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is featured on the David Einhorn Stock Portfolio: Top 10 Stock Picks.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has featured in the 13F portfolio of Greenlight Capital since the fourth quarter of 2023. Back then, this position comprised 268,000 shares. In the coming quarters, the fund steadily loaded up on the stock, increasing the stake by 21%, 44%, and 21%. A massive buying activity was registered in the second quarter of 2025 when the fund increased this holding by more than 550%. Filings for the fourth quarter of 2025 show that the fund owns just over 3 million shares in the pharma firm, down close to 20% compared to filings for the third quarter of 2025.

Is enGene Holdings Inc. (ENGN) the Best Canadian Penny Stock to Invest in Now?

Teva Pharmaceutical Industries Limited (NYSE:TEVA) has been on the radar of elite hedge funds as the firm makes a strategic shift toward innovative, high-margin brand drugs. The best example of this is AUSTEDO, a treatment for tardive dyskinesia whose sales grew significantly in 2025 and are projected to hit $2.5 billion by 2027. Another catalyst for the shares is that in the fourth quarter of 2025, for the first time, Teva’s innovative brands – AUSTEDO, AJOVY, and UZEDY – collectively delivered over $1 billion in a single quarter. Pipeline drugs look promising as well. Teva is developing a potential blockbuster for inflammatory bowel disease. Recent data positions it as a best-in-class therapy. Institutional interest peaked after a $400 million funding agreement with Blackstone to accelerate its development.

While we acknowledge the risk and potential of TEVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TEVA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Billionaire Stan Druckenmiller’s 10 Small and Mid-Cap Stock Picks with Huge Upside Potential and Israel Englander Stock Portfolio: Top 10 Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.